Author/Creator: Claxton, Amy - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Claxton, Amy

11. Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia. (15th August 2018)

Authors:: Nasrallah, Henry A.; Aquila, Ralph; Du, Yangchun; Stanford, Arielle D.; Claxton, Amy; Weiden, Peter J.
Journal:: CNS spectrums
Issue:: Volume 24:Number 4(2019)
Page Start:: 395
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

12. M105. ACTIGRAPHIC MONITORING OF SLEEP-WAKE CYCLE IN SCHIZOPHRENIA OUTPATIENTS RECEIVING A LONG-ACTING INJECTABLE ANTIPSYCHOTIC: FEASIBILITY AND INITIAL RESULTS FROM A PROSPECTIVE RCT. (18th May 2020)

Authors:: Yagoda, Sergey; Wolz, Robin; Weiden, Peter J; Claxton, Amy; Yao, Baiyun; Du, Yangchun
Journal:: Schizophrenia bulletin
Issue:: Volume 46(2020)Supplement 1
Page Start:: S175
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

13. O1–06–06: Therapeutic effects of long‐acting intranasal insulin detemir for Alzheimer's dementia or mild cognitive impairment. (1st July 2013)

Authors:: Craft, Suzanne; Claxton, Amy; Baker, Laura; Cholerton, Brenna; Hanson, Angela; Callaghan, Maureen; Trittschuh, Emily; Arbuckle, Matthew
Journal:: Alzheimer's & dementia
Issue:: Volume 9:Supplement 4S(2013)Part 3
Page Start:: P139
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

14. P3–276: Long‐acting intranasal insulin detemir improves working memory for adults with mild cognitive impairment or early‐stage Alzheimer's dementia. (1st July 2013)

Authors:: Claxton, Amy; Baker, Laura; Hanson, Angela; Cholerton, Brenna; Trittschuh, Emily; Morgan, Amy; Callaghan, Maureen; Arbuckle, Matthew; Behl, Colin; Craft, Suzanne
Journal:: Alzheimer's & dementia
Issue:: Volume 9:Supplement 4S(2013)Part 16
Page Start:: P657
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

15. Safety and Tolerability of Aripiprazole Lauroxil 2-Month Formulation With 1-Day Initiation for Treatment of Schizophrenia in the ALPINE Study. (April 2021)

Authors:: Bidollari, Ilda; Vasios, Alexa; Claxton, Amy
Journal:: CNS spectrums
Issue:: Volume 26:Number 2(2021)
Page Start:: 158
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

16. Social and functional outcomes with two doses of aripiprazole lauroxil vs placebo in patients with schizophrenia: a post-hoc analysis of a 12-week phase 3 efficacy study. (April 2019)

Authors:: Correll, Christoph U.; Stanford, Arielle D.; Claxton, Amy; Du, Yangchun; Weiden, Peter J.
Journal:: Psychiatry research
Issue:: Volume 274(2019)
Page Start:: 176
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗